Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 50, Issue 10, 2002, Pages 1707-1710

  Catani, Marco ^a,b   Mecocci, Patrizia ^a   Tarducci, Roberto ^c   Howard, Robert ^b   Pelliccioli, Gian Piero ^d   Mariani, Elena ^a   Metastasio, Antonio ^a   Benedetti, Claudia ^a   Senin, Umberto ^a   Cherubini, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Monteluce Hospital   (Italy)

^d Ospedale Silvestrini   (Italy)

Author keywords

Aging; Alzheimer's disease; Hypertension; Myoinositol; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HYPERTENSION; MALE; NEUROPSYCHOLOGY; NEURORADIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN; CHOLINE; CHRONIC DISEASE; CREATINE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 18644365321     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50465.x     Document Type: Article

References (21)

1. Tzourio C, Dufouil C, Ducimetiere P et al. for the EVA Study group. Cognitive decline in individuals with high blood pressure. A longitudinal study in the elderly. Neurology 1999;53:1948-1952.
2. Skoog I, Lernfelt B, Landhal S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
3. Petrovitch H, White LR, Izmirilian G et al. Midlife blood pressure and neutitic plaques, neurofibrillary tangles, and brain weight at death: The HAAS. Neurobiol Aging 2000;21:57-62.
4. Forette F, Seux ML, Staessen JA et al. Prevention of dementia in randomized double-blind placebo controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-1351.
5. Rudkin TM, Arnold LA. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol 1999;56:919-926.
6. Glanville NT, Byers DM, Cook HW et al. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1989;1004:169-179.
7. Italian standardization and classification of neuropsychological tests. The Italian Group on the Neuropsychological Study of Aging. Ital J Neurol Sci 1987;(Suppl 8):1-120.
8. Hughes CP, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
10. Raven JC. Revised Manual for Raven's Progressive Matrices and Vocabulary Scale. Windsor, UK: NFER Nelson, 1982.
11. Rey A. L'examen clinique en psychologie. Paris, France: Presses Universitaires de France, 1964.
12. Milner B. Interhemispheric differences in the localization of psychological processes in man. Br Med Bull 1971;27:272-277.
13. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 1996;44:133-138.
14. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001;56:592-598.
15. Miller BL, Moats RA, Shonk T et al. Alzheimer disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437.
16. Kantarci K, Jack CR, Xu YC et al. Regional metabolic patterns in mild cognitive impairment and AD: A 1H-MRS study. Neurology 2000;55:210-217.
17. 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol Aging 1996;17:349-357.
18. Kemper TL, Blatt GJ, Killiany RJ et al. Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys. Acta Neuropathol 2001;101:145-153.
19. Chang L, Ernst T, Poland R et al. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 1996;58:2049-2056.
20. Oppenheimer S, Bryan N, Conturo T et al. Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. Magn Reson Med 1995;33:61-68.
21. Schuff N, Amend DL, Meyerhoff DJ et al. Alzheimer disease: Quantitative H-1 MR spectroscopy imaging of frontal-parietal brain. Radiology 1998;207:91-102.